著者名,論文名,雑誌名,ISSN,出版者名,出版日付,巻,号,ページ,URL,URL(DOI)
Tetsuji Takabayashi (3778786) and Daiya Asaka (11943106) and Yoshitaka Okamoto (5520317) and Tetsuo Himi (460061) and Shinichi Haruna (11943109) and Naohiro Yoshida (479684) and Kenji Kondo (445006) and Mamoru Yoshikawa (425651) and Yasunori Sakuma (11943112) and Kunihiko Shibata (11943115) and Motohiko Suzuki (23512) and Masayoshi Kobayashi (46908) and Ryo Kawata (4810806) and Kenzo Tsuzuki (11943118) and Mitsuhiro Okano (444414) and Takaya Higaki (11943121) and Sachio Takeno (792847) and Satoru Kodama (10522400) and Syuji Yonekura (11943124) and Hiromi Saito (291347) and Akiyo Nozaki (11943127) and Nobuyoshi Otori (11943130) and Shigeharu Fujieda (188194),"sj-pdf-1-ajr-10.1177_19458924211009429 - Supplemental material for A Phase II, Multicenter, Randomized, Placebo-Controlled Study of Benralizumab, a Humanized Anti-IL-5R Alpha Monoclonal Antibody, in Patients With Eosinophilic Chronic Rhinosinusitis",,,SAGE Journals,2022-01-01,,,,https://cir.nii.ac.jp/crid/1871147691528363520,https://doi.org/10.25384/sage.18320176